A family of institutions
working together on the Can Ruti Campus
 

News

14/03/2023 - Research

Breaking barriers in hepatitis C diagnosis and treatment for populations at risk

A study with people who inject drugs evaluated a minimally invasive test based on dried blood spots (DBS) for the monitoring of hepatitis C virus (HCV) infection. The use of DBS samples for HCV RNA detection and genotyping was shown to effectively assess cure after treatment and to differentiate between reinfection and treatment failure. The results support the viability of decentralizing treatment and post-treatment monitoring for people who inject drugs, who frequently face challenges accessing the healthcare system. The study has been published in the Journal of Medical Virology.

09/03/2023 - Research

New method for detecting nanoplastics in blood

A study uses for the first time flow cytometry to detect and measure nanoplastics in peripheral human blood. People with various medical conditions have been included in the study so as to investigate potential differences for nanoplastic accumulation across the population. In addition, mice have been used in a highly controlled environment to compare their nanoplastic levels to that of humans. This study, which has been published at the journal MethodsX.

The IGTP in numbers

  • 795

    Contracted and seconded research staff

  • 289

    Active projects

  • 1022

    Publications

  • 36

    Active patent families

  • 657

    Active clinical trials

  • 18

    Transferred patents

  • 7

    Spin-Offs

The IGTP is an accredited centre of Excellence of the Instituto de Salud Carlos III (Spanish Government)

Instituto de Salud Carlos III


The IGTP is a member of


Governance


With the support of


Accreditation

  • HR Excellence in Research